Ticker | $ Bought |
---|---|
terns pharmaceuticals inc | 8,691,410 |
bristol-myers squibb co | 1,905,330 |
summit therapeutics inc | 1,403,660 |
biontech se | 1,035,790 |
sanofi | 870,732 |
denali therapeutics inc | 457,341 |
travere therapeutics inc | 433,690 |
arcellx inc | 334,040 |
Ticker | % Inc. |
---|---|
johnson & johnson | 557 |
biomarin pharmaceutical inc | 533 |
viking therapeutics inc | 267 |
beigene ltd | 129 |
arcutis biotherapeutics inc | 125 |
zoetis inc | 79.67 |
evolent health inc | 59.9 |
pfizer inc | 59.2 |
Ticker | % Reduced |
---|---|
hutchmed china ltd | -97.91 |
apellis pharmaceuticals inc | -95.71 |
tempus ai inc | -89.68 |
centene corp del | -79.43 |
bio rad labs inc | -70.27 |
charles riv labs intl inc | -68.58 |
doximity inc | -59.73 |
biogen inc | -55.37 |
Ticker | $ Sold |
---|---|
silk rd med inc | -23,127,100 |
outset med inc | -2,936,780 |
teladoc health inc | -2,667,960 |
atricure inc | -4,839,970 |
nevro corp | -1,138,680 |
c4 therapeutics inc | -266,112 |
dynavax technologies corp | -309,476 |
89bio inc | -197,847 |
Bellevue Group AG has about 90.9% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 90.9 |
Others | 9 |
Bellevue Group AG has about 53.4% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
LARGE-CAP | 49.5 |
MID-CAP | 27.1 |
UNALLOCATED | 9.4 |
SMALL-CAP | 8.5 |
MEGA-CAP | 3.9 |
MICRO-CAP | 1.5 |
About 67.4% of the stocks held by Bellevue Group AG either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
S&P 500 | 41.9 |
Others | 32.5 |
RUSSELL 2000 | 25.5 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Bellevue Group AG has 162 stocks in it's portfolio. About 39.2% of the portfolio is in top 10 stocks. MRNA proved to be the most loss making stock for the portfolio. CDNA was the most profitable stock for Bellevue Group AG last quarter.
Last Reported on: 14 Nov, 2024Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
A | agilent technologies inc | 0.00 | 769 | 114,181 | added | 9.23 | ||
AAPL | apple inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
ABBV | abbvie inc | 0.14 | 42,886 | 8,469,130 | added | 1.62 | ||
ABC | cencora inc | 0.26 | 72,053 | 16,217,700 | reduced | -19.34 | ||
ABT | abbott labs | 3.22 | 1,743,940 | 198,826,000 | added | 8.58 | ||
ACCD | accolade inc | 0.04 | 640,865 | 2,467,330 | reduced | -23.94 | ||
ACLX | arcellx inc | 0.00 | 4,000 | 334,040 | new | |||
ADMA | adma biologics inc | 0.01 | 25,900 | 517,741 | reduced | -16.18 | ||
AGIO | agios pharmaceuticals inc | 2.69 | 3,735,920 | 165,987,000 | reduced | -3.7 | ||
ALGN | align technology inc | 0.59 | 143,996 | 36,621,100 | added | 0.01 | ||
ALKS | alkermes plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
ALNY | alnylam pharmaceuticals inc | 3.60 | 809,095 | 222,525,000 | reduced | -12.04 | ||
ALT | altimmune inc | 0.09 | 863,660 | 5,302,870 | added | 43.94 | ||
AMEH | astrana health inc | 0.24 | 254,182 | 14,727,300 | added | 1.42 | ||
AMGN | amgen inc | 0.13 | 25,152 | 8,104,230 | reduced | -14.82 | ||
AMRX | amneal pharmaceuticals inc | 0.01 | 76,414 | 635,764 | added | 21.76 | ||
ANNX | annexon inc | 0.50 | 5,157,290 | 30,531,200 | unchanged | 0.00 | ||
APLS | apellis pharmaceuticals inc | 0.01 | 19,046 | 549,287 | reduced | -95.71 | ||
ARQT | arcutis biotherapeutics inc | 0.01 | 39,500 | 367,350 | added | 125 | ||
ARVN | arvinas inc | 0.95 | 2,386,600 | 58,782,000 | reduced | -0.18 | ||